Cargando…
New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
Antiretroviral therapy (ART) controls human immunodeficiency virus 1 (HIV-1) replication and prevents disease progression but does not eradicate HIV-1. The persistence of a reservoir of latently infected cells represents the main barrier to a cure. “Shock and kill” is a promising strategy involving...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402914/ https://www.ncbi.nlm.nih.gov/pubmed/34452425 http://dx.doi.org/10.3390/v13081560 |